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Bacteria alter the biophysical properties of their membrane lipids in response to
environmental cues, such as shifts in pH or temperature. In essence, lipid composition
determines membrane structure, which in turn influences many basic functions, such
as transport, secretion, and signaling. Like other members of the phylum Bacteroidetes,
the oral anaerobe Porphyromonas gingivalis possesses the ability to synthesize a variety
of novel membrane lipids, including species of dihydroceramides that are distinct,
yet similar in structure to sphingolipids produced by the human host. The role of
dihydroceramides in the physiology and pathogenic potential of the human microbiota
is only beginning to be explored; yet there is increasing data indicating that these lipids
play a role in human diseases, such as periodontitis and multiple sclerosis. Here, we
report on the identification of a gene (PG1780) in the chromosome of P. gingivalis strain
W83 encoding a putative serine palmitoyltransferase, the enzyme that catalyzes the
first step in sphingolipid biosynthesis. While we were able to detect dihydroceramides in
whole lipid extracts of P. gingivalis cells as well as crude preparations of outer membrane
vesicles, sphingolipids were absent in the PG1780 mutant strain. Moreover, we show
that the synthesis of sphingolipids plays an essential role in the long-term survival of
the organism as well as its resistance to oxidative stress. Further, a PG1780 mutant
displayed much lower activity of cell-associated arginine and lysine gingipains, yet
slightly higher activity in the corresponding culture supernates, which we hypothesize
is due to altered membrane properties and anchoring of these proteases to the
cell surface. In addition, we determined that sphingolipid production is critical to the
presentation of surface polysaccharides, with the mutant strain displaying less K-antigen
capsule and more anionic polysaccharide (APS). Overall, we have discovered that, in
addition to their role in pathogenicity, the synthesis of sphingolipids is critical to the
cellular homeostasis and persistence of this important dental pathogen.
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Frontiers in Microbiology | www.frontiersin.org 1 November 2016 | Volume 7 | Article 1919
fmicb-07-01919 November 26, 2016 Time: 12:18 # 2
Moye et al. Loss of Sphingolipids Modulates Cell Surface
INTRODUCTION
Cell membranes of eukaryotes and prokaryotes are fluid, yet
resilient composites of proteins and lipids (Kaiser et al., 2011).
A great variety of lipid structures are found in the membranes
of cellular organisms, and the stability of the membranes is
maintained due to the amphipathic nature of the lipids that
comprise it. In the simplest terms, phospholipids consist of
hydrophobic long-chain fatty acids capped with a polar head
group. The structured association of the hydrophobic tails
permits the formation of a basic lipid bilayer, critical for cellular
life. Further, these fatty acyl side-chains modulate membrane
fluidity and adjustments in the structure of these lipids alter the
biophysical properties of the membrane (Los and Murata, 2004).
One major class of amphipathic lipids is glycerol phospholipids,
consisting of a glycerol platform to which two hydrophobic
fatty acid side-chains and a hydrophilic phosphate group,
which can be modified by the addition of various functional
groups. These lipids are found in the membranes of both
eukaryotic and prokaryotic organisms. In addition to glycerol
phospholipids, eukaryotic membranes are populated with lipid
species characterized by a sphingoid base (or long chain base), an
amino alcohol with a hydrocarbon tail, which is attached by an
amide bond to a fatty acid chain (Futerman and Hannun, 2004).
This class of lipids, called sphingolipids, was first described in
Thudichum (1884), who alluded to the curious structure of these
lipids and introducing the term “sphingo-” likely in reference to
the Sphinx of ancient mythology. Sphingolipids not only serve as
structural components of the lipid bilayer, but can also associate
with collections of proteins and other lipids, often sterols, to
form energetically favorable partitions in the membrane known
as lipid rafts (Lingwood and Simons, 2010; Nicolson, 2014).
In addition, multiple species of sphingolipids are now known
to function as regulators of signaling pathways within human
cells (Hannun and Obeid, 2008). Though originally thought to
exclusively populate the membranes of eukaryotic organisms, it is
now well established that a variety of bacterial species, including
many members of the prokaryotic phylum Bacteroidetes, are
capable of synthesizing sphingolipids (Olsen and Jantzen, 2001),
yet the importance of these unusual lipids in physiology and
pathogenic capacity of the human microbiota is only beginning
to be explored.
The human oral cavity is inhabited by multiple bacterial
species proficient in sphingolipid biosynthesis including
Porphyromonas gingivalis, Tannerella forsythia, and Prevotella
intermedia (Nichols, 1998; Nichols et al., 2004, 2011). Of
these sphingolipid-producing organisms, the impact of the
sphingolipids generated by P. gingivalis on human cells has been
the most extensively characterized thus far. P. gingivalis is an
obligate anaerobe that is strongly implicated in the progression
of adult periodontal disease (Socransky and Haffajee, 2005).
The oral cavities of healthy adults are persistently colonized
by a diverse and relatively stable collection of microbes. In
periodontal disease, this homeostasis is disrupted, and there is
a shift in the composition of the microbiota to higher levels of
Gram-negative anaerobes, resulting in chronic inflammation
and bone resorption. P. gingivalis has evolved a number of
virulence determinants that permit it to persist within the oral
cavity and elicit disease, including a carbohydrate-rich capsule,
novel lipopolysaccharides, a host of proteolytic enzymes (Cugini
et al., 2013), and the synthesis of sphingolipids appears to be an
additional contributor to the virulence of this organism.
Though similar in structure to those produced by mammalian
species, the sphingolipids synthesized by P. gingivalis that have
been described thus far contain some notable differences that
permit them to be distinguished from those generated by the
human host (Nichols et al., 2004). For example, one common
sphingoid base found in the sphingolipids of mammalian species
is sphingosine, which contains a double bond between C4 and
C5, and when attached to a fatty acid chain via an amide linkage,
this lipid is termed a ceramide (Futerman and Hannun, 2004).
However, the sphingoid base of P. gingivalis, which can be 17,
18, or 19 carbons in length, is fully saturated and isobranched for
the odd numbered carbon chains. This sphingoid base is referred
to as sphinganine (dihydrosphingosine) or dihydroceramide
(DHC) once attached by an amide bond to a fatty acid chain,
which in the case of P. gingivalis is predominantly 3-hydroxy
isobranched C17 (Nichols et al., 2004). Notably, the distinct DHC
platform produced by P. gingivalis has also been observed in
several additional members of the human microbiome (Nichols
et al., 2011). Both eukaryotic and prokaryotic organisms also
attach a variety of head groups to their sphingolipids via the
hydroxy group attached to the first carbon of the sphingoid
base. To date, three species of DHCs have been observed in
membrane extracts of P. gingivalis, including the unmodified
DHC platform, phosphoethanolamine DHC (PE DHC) and
phosphoglycerol DHC (PG DHC) (Nichols et al., 2004). PG DHC
can also be modified by the addition of another saturated fatty
acid, usually isobranched C15, via an ester linkage to the 3-
hydroxy of the fatty acid chain (Nichols et al., 2004). Thus, clear
distinctions are apparent between the sphingolipids produced
by human and prokaryotic species, owing perhaps to different
evolutionary contexts and genome size constraints; however, the
basic structure of the bacterial versions of these unique lipids
is similar to those found in eukaryotic species suggesting that
they may perform similar functions to those associated with their
counterparts in eukaryotic systems.
Recent studies have demonstrated that multiple species
of bacterially derived DHCs can be detected at numerous
sites throughout the human body, including gingival tissue
from healthy sites as well as sites with severe gingivitis
(Nichols et al., 2011). Therefore, even though the majority of
sphingolipid proficient bacteria are confined to the oral cavity
and gastrointestinal tract, it appears that DHCs, from lysed cells,
invading bacteria or outer membrane vesicles (OMVs) derived
from bacteria, are capable of penetrating human tissues and
influencing disease progression. For example, in vitro studies
with purified P. gingivalis DHCs, which were shown to be
identical to the lipids detected in diseased tissues, determined that
these lipids can modulate prostaglandin production, stimulate
inflammatory responses in fibroblasts (Nichols et al., 2004),
inhibit osteoblast differentiation and function (Wang et al., 2010),
promote apoptosis in chondrocytes (Röhner et al., 2012) and
endothelial cells (Zahlten et al., 2007), and increase IL-6 secretion
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in dendritic cells (Nichols et al., 2009). In addition, isolated
sphingolipids from P. gingivalis have been shown to increase
inflammation in a mouse model of autoimmune disease (Nichols
et al., 2009).
While much is known about the pathways of sphingolipid
synthesis and the impact of these lipids on the physiology of
eukaryotic organisms, there have been very few investigations
pertaining to the genetics or biosynthesis of sphingolipids by
prokaryotes. Perhaps the best-characterized bacterial species
capable of producing sphingolipids is Bacteroides fragilis, a
common commensal found in the gastrointestinal tract of healthy
humans. The first step in the synthesis of sphingolipids is
the condensation of serine and a long chain fatty acid to
yield 3-ketodihydrosphingosine, and this reaction is catalyzed
by the enzyme serine palmitoyltransferase (SPT). In B. fragilis,
it has been predicted that BF2461 encodes a functional SPT
(An et al., 2011; Wieland Brown et al., 2013), and the SPT
activity of this enzyme has recently been confirmed biochemically
(D. J. Campopiano personal communication). When this gene
was deleted and the lipid profile of the mutant and parental
strain were compared, it was determined that B. fragilis
produces both unmodified DHC and PE DHC as well as an
α-galactosylceramide, which appears to modify immune cell
response (Wieland Brown et al., 2013). These and potentially
other sphingolipids produced by B. fragilis play critical roles in
the physiology of the organism. For example, cultures of B. fragilis
treated with myriocin, in order to inhibit SPT, displayed several
alterations to its physiology including reduced survival after
temperature and oxidative stress, and cultures treated with this
inhibitor were less able to survive long-term incubation (An et al.,
2011). Importantly microdomains, enriched with sphingolipids,
were absent from the membranes of cells when SPT was inhibited,
and these findings led the authors to suggest that lower levels of
DHCs in the membrane may destabilize lipid rafts (populated
and stabilized by sphingolipids) and hinder the transmission
of signals of environmental stress across the membrane (An
et al., 2011). Therefore, the production of sphingolipids is critical
to the survival of B. fragilis and furthermore synthesis likely
impacts its interaction with the host due to changes in membrane
composition. We have identified a gene (PG1780) in the oral
anaerobe P. gingivalis strain W83 with high sequence similarity
(89%) to the SPT of B. fragilis. In this report, we characterize
a mutant strain bearing a deletion of PG1780 and subsequently
synthesis of all lipid species containing a sphingoid base. Our
results demonstrate the importance of sphingolipids in the ability
of P. gingivalis to persist and maintain membrane homeostasis,
which consequently impact its capacity to antagonize the human
host.
MATERIALS AND METHODS
Bacterial Strains and Mutant
Construction
Porphyromonas gingivalis strain W83 and derivatives, including
the K-antigen capsule null mutant 1PG0106, which was
generated previously (Davey and Duncan, 2006) were
routinely grown on agar plates containing Trypticase Soy Broth
(Becton, Dickinson and Company, Franklin Lakes, NJ, USA)
supplemented with 5 µg ml−1 hemin, 1 µg ml−1 menadione,
and 5% defibrinated sheep blood (Northeast Laboratory Services,
Winslow, ME, USA) and incubated at 37◦C in an anaerobic
chamber (Coy Lab Products, Grass Lake, MI, USA) with an
atmosphere containing 5% hydrogen, 10% carbon dioxide, and
85% nitrogen. When desired, planktonic cultures of P. gingivalis
were grown in Tryptic Soy Broth (TSB) medium (without
dextrose) (Becton, Dickinson and Company, Franklin Lakes,
NJ, USA) supplemented with 5 µg ml−1 hemin and 1 µg ml−1
menadione (TSBHK). A deletion of PG1780 was generated using
the NEBuilder HiFi DNA assembly cloning kit (New England
BioLabs, Ipswich, MA, USA) as described using the instructions
provided by the manufacturer. Briefly, primers (Supplementary
Table S1) were designed to generate upstream and downstream
products of approximately 1 kb flanking PG1780 as well as an
erythromycin resistance gene (ermF) obtained from plasmid
pVA2198 (Fletcher et al., 1995). Primers were designed to
incorporate sufficient overlapping regions at the ends of the
products to permit the assembly of the erythromycin gene with
the flanking regions of PG1780. Products were generated using
Phusion High-Fidelity PCR Master Mix with HF Buffer (New
England BioLabs, Ipswich, MA, USA), and equal portions of
these products were mixed and incubated with the NEBuilder
HiFi DNA assembly cloning kit according to the manufacturer’s
instructions. The product of the assembly cloning kit was
amplified by PCR (using the Phusion High-Fidelity PCR Master
Mix) and used to transform P. gingivalis W83 by electroporation.
Complementation of 1PG1780 was achieved by inserting a
functional copy of PG1780 into the plasmid pTCOW (Gardner
et al., 1996) to produce pTCOW-1780. Plasmid pTCOW-1780
was then transformed into W83 1PG1780 by electroporation.
The presence of pTCOW-1780 in 1PG1780 was maintained by
supplementing media with 1 µg ml−1 tetracycline.
Bacterial Growth
To monitor growth, cultures of P. gingivalis strain W83 and
derivatives were inoculated into TSBHK, grown for 24 h and
then diluted into fresh TSBHK media. After approximately 12 h
of growth (OD600 is typically 0.3–0.4), cultures were normalized
with pre-reduced TSBHK media to an equal optical density
(usually an OD600 of 0.35). Throughout exponential phase, the
optical density (600 nm) of cultures was routinely recorded and
then every 24 h once the cultures entered stationary phase. To
monitor the number of viable cells, cultures were serially diluted,
and 10 µl of each dilution was spotted on blood agar plates in the
anaerobic chamber. After 9 days, plates were removed from the
anaerobic chamber and photographed.
Preparation of Outer Membrane Vesicles
Cultures of P. gingivalis were grown in TSBHK for approximately
24 h and used to inoculate 50 ml of TSBHK, and this culture
was grown for an additional 24 h. This culture was then added
to 450 ml of TSBHK and grown another period of 24 h in order
to generate a dense bacterial culture. At this point, the culture
was removed from the chamber and centrifuged to collect cells;
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aliquots of the pellet were obtained and frozen at −20◦C in
preparation for lipid analysis. Supernates were filtered through
a 0.22 µm pore size filter and subjected to centrifugation at
100,000 × g for 50 min. These pellets were pooled, suspended
in phosphate buffered saline (PBS), filtered through a 0.2 µm
syringe filter, and stored at 4◦C until lipid analysis was performed.
Lipid Extraction, Fractionation, and
Characterization
Lipids were extracted from bacterial samples using the method
of Bligh and Dyer (Bligh and Dyer, 1959) as modified
by Garbus et al. (1963). Bacterial samples were dissolved
in chloroform:methanol:water (1.33:2.67,1, v/v/v, 4 ml) as
previously described (Nichols et al., 2004). The mixture was
vortexed at 15 min intervals for 2 h, and the mixture was
supplemented with 0.75 ml of chloroform and 0.75 ml of a buffer
comprised of 2 N KCl and 0.5 N K2HPO4. The mixture was
vortexed and centrifuged (2000 × g) at 20◦C for 4 h. The lower
organic phase was removed and dried under nitrogen.
Mass Spectrometry
Lipid samples were dissolved in the neutral HPLC solvent
(hexane:isopropanol:water, 6:8:0.75, v/v/v), the samples were
centrifuged at 2500 × g for 10 min, and the supernates were
removed for HPLC-mass spectrometric analysis. The bacterial
lipid samples were injected over a normal phase column
(Ascentis R©Si, 3 cm × 2.1 mm, 5 mm, Supelco Analytical)
interfaced with an API Qtrap 4000 instrument (Sciex). Neutral
HPLC solvent was delivered under isocratic conditions with a
Shimadzu LC-10ADvp pump at a flow rate of 100–120 µl min−1.
Total ion chromatograms were acquired using negative ion mode
and a mass range of 100 to 1800 amu, and MS/MS acquisitions
used parameters optimized for specific lipid products. Collision
energies for negative ion products were typically between
−30 and −55 volts depending on the precursor ion under
investigation. Negative ion ESI was carried out at −4,500 V, with
a declustering potential of −90 V, focusing potential of −350 V,
and entrance potential of −10 V. The ion source temperature
was maintained at 300◦C. Multiple reaction monitoring (MRM)
negative ion transitions for the serine dipeptide lipids of
P. gingivalis, Lipid 654 and Lipid 430, were m/z 653.5/381.4
and m/z 430.3/382.3, respectively. Low mass (LM) and high
mass (HM) phosphoethanolamine dihydroceramides (PE DHC)
were monitored by m/z 677.5/240.0 and m/z 706.2/140.0 ion
transitions, respectively. LM and HM unsubstituted PG DHC
(unsub PG DHC) lipids were monitored by m/z 709.0/171.4
and m/z 737.0/171.4 ion transitions, respectively. LM and HM
substituted phosphoglycerol dihydroceramides (sub PG DHC)
were monitored by m/z 933.0/171.4 and m/z 961.5 /171.4 ion
transitions, respectively. The MRM peaks were electronically
integrated for comparison of lipid class recoveries.
Electron Microscopy
In order to visualize surface polysaccharides, colonies of
P. gingivalis W83 and derivatives were scraped from blood agar
plates and stained with ruthenium red as previously described
(Priyadarshini et al., 2013). Transmission electron microscopy
and image analysis was performed by the electron microscopy
core at the University of Florida.
Preparation of Autoclaved Extracts
Porphyromonas gingivalis strain W83 and derivatives were
inoculated into TSBHK and grown for approximately 24 h.
Cultures were diluted into fresh TSBHK, grown to mid-
exponential phase and normalized to an OD600 of approximately
1.0. Cultures were diluted 1/10, and 10 µl aliquots of each culture
were spotted on blood agar plates. After 3, 5, and 7 days, cultures
were scraped off the plates and placed into cuvettes containing
sterile distilled water. Cultures were normalized to an OD600 of
0.5. 1.5 ml of the suspension was pelleted and half the supernatant
was removed. The cells were resuspended in the final 0.75 ml and
autoclaved at 120◦C for 30 min. Once cooled, the extracts were




Enzyme-linked immunosorbent assays (ELISAs) for the detection
of surface polysaccharides were performed as previously
described (Bainbridge et al., 2015). Briefly, autoclaved extracts
of P. gingivalis W83 and derivatives were diluted in 50 mM
carbonate/bicarbonate buffer, pH 9.6 and serially diluted in a 96-
well plate; plates containing diluted antigen were incubated at
4◦C overnight. After washing plates with PBS containing 0.05%
Tween 20 (PBS/Tween), a solution of 5% milk powder in PBS was
used to block wells for approximately 1 h at room temperature.
After washing with PBS/Tween, wells were incubated for 1 h
at 37◦C with a serotype specific antiserum previously generated
against P. gingivalis strain W83 (Alberti-Segui et al., 2010),
diluted to a concentration of 1:2000 in PBS containing 0.1%
Tween 20 and 0.1% bovine serum albumin (PTB), to detect
the capsule. Next, wells were washed with PBS/Tween and
then incubated for 1 h at 37◦C with a goat anti-rabbit IgM-
HRP antibody diluted at 1:5000 in PTB. To detect anionic
polysaccharide (APS), the monoclonal antibody 1B5 (kindly
provided by Michael Curtis, Queen Mary University of London,
London, England) was used at a concentration of 1:100, and an
anti-mouse IgG-HPR antibody at 1:5000 was used as a secondary.
After a final wash with PBS/Tween, wells were incubated with
3,3′,5,5′-Tetramethylbenzidine (Sigma–Aldrich, St. Louis, MO,
USA) until sufficient color appeared. The reaction was stopped
with an equal portion of 1 M HCl, and the absorbance was
recorded at OD450.
Gingipain Assay
The activity of arginine and lysine gingipains was assessed as
previously described (Veillard et al., 2012). Briefly, cultures were
inoculated into TSBHK, grown for 24 h and diluted into fresh
TSBHK. Once the cultures reached exponential phase, they were
normalized to OD600 = 1.0, and 1 ml of each culture was removed
from the anaerobic chamber and centrifuged. The supernates of
these cultures were saved, while the pellets were resuspended
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in assay buffer (200 mM Tris, 5 mM CaCl2, 150 mM NaCl,
and 10 mM L-cysteine at pH 7.6). Cultures and supernatants
were diluted 1/10 in assay buffer and then serially diluted in
assay buffer across a 96-well microtiter plate. The initial optical
density at 405 nm was recorded, and the plates were placed
in a 37◦C incubator for 10 min to equilibrate the temperature.
N-α-benzoyl-L-arginine-p-nitroanilide (BAPNA) or N-α-acetyl-
L-lysine-p-nitroanilide (ALPNA) were added to the wells at a final
concentration of 1 mM, and the microtiter plates were incubated
for 2 h at 37◦C. The final optical density (OD405) of the wells was
recorded, and the difference between the initial and final optical
density was reported.
H2O2 Assay
Cultures of P. gingivalis W83 and derivatives were inoculated
in TSBHK, grown for 24 h and diluted into fresh pre-reduced
TSBHK. After approximately 12 h of growth, cultures were
adjusted to an OD600 of ∼0.35 and split into four aliquots.
Water or fresh H2O2 (Fisher Scientific) was placed in the
anaerobic chamber and diluted into pre-reduced water. H2O2
(final concentration of 150, 200, or 250 µM) or water (as a
negative control) was added at equal volumes to the cultures. The
initial optical density (OD600) was recorded, and cultures were
monitored over the next 30 h.
RESULTS
Deletion of PG1780, Predicted to be a
Serine Palmitoyltransferase, Generated a
Sphingolipid Null Mutant
Data from previous investigations have suggested an important
role for bacterially derived sphingolipids in periodontal disease
progression (Nichols, 1998; Nichols et al., 2004, 2012; Nichols
and Rojanasomsith, 2006; Wang et al., 2010) and inflammatory
autoimmune diseases including a murine model of multiple
sclerosis [experimental allergic encephalomyelitis (EAE)]
(Nichols et al., 2009). However, the anabolic enzymes critical
to the assembly of sphingolipids and their deployment to the
membrane in P. gingivalis have not been described. SPT is a
pyridoxal-dependent enzyme that catalyzes the first step in the
biosynthesis of sphingolipids, i.e., the condensation of serine
and palmitoyl CoA to generate 3-ketodihydrosphingosine. Initial
bioinformatic searches using homologies of this enzyme from
mammal sources and then eventually the enzyme encoded
by B. fragilis (BF2461) (An et al., 2011; Wieland Brown et al.,
2013) suggested that P. gingivalis contains a gene encoding
this transferase (PG1780 in strain W83), which has often been
annotated as either 8-amino-7-oxononanoate synthetase or
2-amino-3-ketobutyrate CoA ligase. Our analysis of PG1780
revealed that the enzyme is part of the Conserved Protein
Domain Family cd06454 sequence cluster, and this led us to
suspect that PG1780 encodes an SPT in P. gingivalis strain
W83. To test this hypothesis, we replaced PG1780 with an
erythromycin resistance cassette via allelic exchange mutagenesis
(described in the Materials and Methods section) and analyzed
the lipid composition of the resulting mutant. As expected,
the mutant strain (1PG1780), scraped from blood agar plates,
was unable to synthesize dihydroceramides (DHCs) while the
parental strain and complemented mutant strain (1PG1780
pTCOW-1780) produced comparable levels of these lipid species
(Figure 1A). To our knowledge, this is the first mutant generated
in P. gingivalis that is deficient in DHC synthesis. Importantly,
the strain lacking PG1780 still maintained high levels of the
serine dipeptide lipid 654, which is produced through a separate
biosynthetic pathway (Clark et al., 2013).
FIGURE 1 | Deletion of PG1780 renders Porphyromonas gingivalis strain W83 unable to synthesis sphingolipids. Colonies of P. gingivalis strain W83,
1PG1780 and the complemented strain (1PG1780 pT-COW-1780) were removed from blood agar plates (A), or P. gingivalis strain W83 was grown in TSBHK, cells
were pelleted (W83 cell) and the supernate was used to prepare outer membrane vesicles (W83 OMV) (B). Bacterial lipids were extracted from these samples as
described in section “Materials and Methods.” Data are representative of three (A) or two (B) replications showing similar results. The dihydroceramides (DHC) of
P. gingivalis can be modified by the addition of phosphoethanol (PE) or phosphoglycerol (PG). Further, the sphingoid base ranges in length from 17 to 19 carbons
yielding low, intermediate or high mass DHCs. We report here the low (LM) and high (HM) species. In the case of PG DHC, a C15 fatty acid can sometimes be found
attached to the long chain base, indicated as PG DHCs with (sub) or without (unsub). Finally, lipid 654 and lipid 430 are lipid species that appear in extractions of
DHCs but are synthesized by a separate pathway and are not sphingolipids.
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In addition to extracting lipid samples from P. gingivalis
growing on plates, we also grew planktonic cultures and looked
for the presence of DHCs. As expected, we found a similar profile
of DHCs in pelleted cells of P. gingivalis W83 grown in liquid
culture. We also isolated crude preparations of OMVs from these
P. gingivalis cultures and found that they were enriched with
DHCs (Figure 1B) indicating that these lipids are localized to the
outer leaflet of the outer membrane.
Long-Term Survival Is Diminished in a
P. gingivalis Strain Unable to Produce
Dihydroceramides
In previous studies of B. fragilis, it was demonstrated that a
reduction in DHC production, due to inhibition of SPT using
myriocin, diminished the long-term survival of the organism (An
et al., 2011), i.e., the optical density of the treated and untreated
cultures remained comparable throughout stationary phase but
there was a pronounced decrease in the number of viable cells
recovered from the cultures treated with myriocin. Based on
these results, we attempted to determine the impact of deleting
PG1780 on the growth and long-term survival of P. gingivalis. In
growth experiments, we found that 1PG1780 grew at a slightly
slower rate to the parental strain (a doubling time of 4.4 h
vs. 3.9 h, respectively). Based on the results observed in B.
fragilis, we also monitored the long-term survival of 1PG1780
compared to the parental strain. Interestingly, we noted that after
approximately 30 h the optical density of the mutant dropped off
sharply and continued to diminish over time while the turbidity
of parental strain decreased only slightly over the course of
the experiment (Figure 2). To demonstrate that this decrease
in optical density represented the lysis of bacterial cells and
not simply auto-aggregation, we serially diluted cultures, spotted
10 µl of dilutions on blood agar plates and incubated the plates
for 9 days (Supplementary Figure S1). As expected, the number
of colonies recovered from 1PG1780 decreased dramatically
after 30 h while recovery from the parental strain remained
relatively stable. We also noted that isolated colonies recovered
from 1PG1780 were much smaller and more pleomorphic than
the parental strain. In addition, the parental strain was able to
clear much more of the sheep red blood cells (as evidenced by the
clear halo around the colonies) than the sphingolipid deficient
mutant.
Deletion of PG1780 Impacts Cell Surface
Properties of P. gingivalis
As indicated, lipid composition influences membrane structure,
and thereby function. Since bacterial capsules are typically
anchored to the cell surface, we hypothesized that the DHCs
could play a role in the presentation of capsule (or another surface
polysaccharide) on the cell surface. To explore this hypothesis, we
examined 1PG1780 for changes in the presentation of surface
polysaccharides by staining the cells with ruthenium red and
imaging with transmission electron microscopy, as previously
described (Priyadarshini et al., 2013). As shown in Figure 3,
the 1PG1780 mutant lacks the dense layer of polysaccharide at
the cell surface, indicating that synthesis of DHCs impacts the
presentation of surface polysaccharides.
Based on these electron micrographs, we began analyzing
specific species of surface glycans to determine if any were
altered due to the mutation of PG1780. To accomplish this, we
grew 1PG1780, 1PG0106 (capsule null strain) and the parental
strain to exponential phase and then diluted cultures 1/10 and
spotted 10 µl of each culture on blood agar plates to simulate
the natural state of the bacteria, i.e., in biofilms. After 3, 5,
and 7 days, we removed plates from the chamber and observed
the colony morphology. The images of bacterial colonies and
ELISA results looked similar for samples collected on days 3,
5, and 7; therefore, we show here only the results from day
5. Interestingly, colonies of 1PG1780 appeared very different
from 1PG0106 and the parental strain (Figure 4). Colonies
of 1PG1780 were consistently much darker and thinner than
the other two strains, agreeing with our observations during
the long-term survival experiments (Supplementary Figure S1).
To analyze the carbohydrates presented on the surface of the
cell, colonies of all three strains were scraped from these
plates, normalized by optical density and autoclaved. ELISAs
was performed with these antigens using the αW83 antisera to
assess the K-antigen capsule and 1B5 to determine the levels
of APS. As expected, we found that 1PG0106, which was
used here as a negative control, gave very little cross reactivity
to the capsule antisera and low levels of APS (Figure 4).
Interestingly, we found that 1PG1780 produced less capsule
polysaccharide than the parental strain; however, the levels of
polysaccharide were nowhere near as low as1PG0106 (Figure 4).
Furthermore, the APS presented by 1PG1780 was higher than
the parental strain and 1PG0106. Overall, these initial studies
indicate that the surface glycans presented by P. gingivalis are
influenced by the presence of sphingolipids. Further biochemical
studies are underway to obtain a more detailed analysis of
the impact of sphingolipids on the presentation of surface
glycans.
Levels of Gingipains Are Dramatically
Altered in a Strain Lacking Sphingolipids
The arginine and lysine gingipains are major virulence
determinants of P. gingivalis and can be anchored to the surface
of the cell, released via outer membrane vesicles, or secreted. Due
to the lower level of proteolysis observed by the mutant on blood
agar plates (data not shown), we next investigated whether the
deletion of PG1780 impacted the activity of arginine and lysine
gingipains. To monitor gingipain activity, P. gingivalis W83 and
1PG1780 were grown to mid-exponential phase. The cells were
pelleted, the supernatant was removed, and the activity of cell-
associated and cell free gingipains was determined as described
in the section “Materials and Methods.” We determined that the
mutant strain produced substantially lower arginine and lysine
gingipain activity in the whole cell fraction when compared to
the parental strain (Figure 5). Further, 1PG1780 consistently
produced slightly more supernate-associated gingipain activity
than the parental strain, potentially indicating that the lower
level of cell-associated gingipains may be due to an increased
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FIGURE 2 | Growth curve determined that survival of the sphingolipid deficient strain (1PG1780) is compromised during stationary phase. P. gingivalis
parent strain W83 and the 1PG1780 mutant (deletion of a serine palmitoyltransferase) were grown in TSBHK media. Data are representative of three replications
showing similar results.
FIGURE 3 | A sphingolipid deficient strain (1PG1780) produces less surface polysaccharide than the parent strain P. gingivalis W83. Cells were stained
with ruthenium red as described in the section “Materials and Methods” and viewed by transmission electron microscopy. Once stained, the surface polysaccharides
appear as a dense layer surrounding the cell membrane. We consistently observed much lighter staining around the surface of 1PG1780, indicating that this mutant
produces lower levels of polysaccharide at the cell surface.
release of gingipains into the supernatant, perhaps as a result of
changes to membrane composition.
Deletion of PG1780 Reduced the Ability
of P. gingivalis to Survive Oxidative
Stress
During our characterization of 1PG1780, we consistently
observed that the mutant performed poorly after exposure to
oxygen, even for very short intervals (For example, the parental
strain and 1PG1780 were serially diluted and spotted in the
anaerobic chamber during our long-term survival assays and
grown for 9 days. When strains were diluted and plated outside
the chamber, the mutant took substantially longer to grow on
blood agar plates). To determine if deletion of PG1780 impacts
the ability of P. gingivalis to survive oxidative stress, we grew
1PG1780 and the parental strain to early exponential phase and
treated cultures with 150, 200, or 250 µM hydrogen peroxide or
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FIGURE 4 | The surface polysaccharides of P. gingivalis are altered in a strain unable to produce sphingolipids. P. gingivalis W83, 1PG1780 and
1PG0106 (a strain that lacks the K1 capsule) were grown to mid-exponential phase in TSBHK, normalized, diluted 1/10 and spotted in 10 µl aliquots on blood agar
plates. After 5 days, plates were removed from the anaerobic chamber and photographed (A). Colonies were removed from these plates, normalized by optical
density and autoclaved to generated antigen. Enzyme-linked immunosorbent assays (ELISAs) were performed to detect K1 capsular polysaccharide (B) and anionic
polysaccharide (APS) (C). Plates grown to 3 or 7 days were also photographed and used to generate antigen for ELISAs, and both additional time points showed
similar results. Data represent the average of three biological replicates with error bars indicating the standard deviation. P < 0.05 (by the Student t-test) was
observed when W83 and 1PG1780 were compared at antigen dilutions between 1,000–2,000 (A) and 1,000–4,000 (B).
FIGURE 5 | The proteolytic activity of gingipains is lower in a strain of P. gingivalis that is unable to produce sphingolipids. P. gingivalis W83 and
1PG1780 were grown to mid-exponential phase in TSBHK media, and a gingipain assay was performed on these cultures as described in the section “Materials
and Methods.” Cultures were centrifuged, the supernatant was removed and saved while the pellet was resuspended in assay buffer. The bacterial cells (cells) and
supernatant (sup) were diluted 1/10 and then serially in assay buffer. After reading the initial optical density (OD405 I), samples were treated with either
N-α-benzoyl-L-arginine-p-nitroanilide (BAPNA) and N-α-acetyl-L-lysine-p-nitroanilide (ALPNA) to assess the arginine (A) or lysine (B) gingipain activity, respectively.
Samples were incubated for 2 h, and the final optical density (OD405F) was recorded. Results are reported as 1OD405, that is OD405F – OD405 I. Data represent the
average of three biological replicates with error bars displaying the standard deviation. P < 0.05 (by the Student t-test) was observed when W83 cell and 1PG1780
cell were compared at dilutions between 10–1280 (A) and 10–320 (B). P < 0.05 (by the Student t-test) was observed when W83 sup and 1PG1780 sup were
compared at dilutions between 10–160 (A) and 10–80 (B).
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water as a control. We found that the parental strain was able to
survive the addition of all concentration of hydrogen peroxide we
tested. Cultures treated with the highest concentration (250 µM)
decreased in density after the initial administration of H2O2 but
were able to recover and resume growth after approximately
30 h (Figure 6). In contrast, cultures of 1PG1780 treated with
200 or 250 µM H2O2 were quickly killed and were not able
to recover after 30 h. Cultures of the mutant treated with the
lowest concentration of H2O2 (150 µM) did initially decrease in
density after treatment but were able to recover by the end of the
experiment. Thus, overall,1PG1780 is much more sensitive than
the parental strain to treatment with H2O2.
DISCUSSION
Far from acting solely as structural components of mammalian
membranes, it is becoming increasingly evident that
sphingolipids can serve a wide range of functions within
cells, including partitioning into functional microdomains
populated by other lipid species and integral membrane proteins
(lipid rafts), as well as acting as signaling molecules for a
diverse array of cellular processes (Hannun and Obeid, 2008;
Nicolson, 2014). In light of the numerous, critical cellular
functions associated with sphingolipids, it is not surprising to
find that pathogenic microorganisms have evolved mechanisms
to manipulate and interfere with sphingolipid signaling in order
to promote their pathogenicity (Heung et al., 2006). Moreover,
although sphingolipids were once thought to be exclusively
produced by eukaryotes, it is now apparent that prokaryotes can
also synthesize lipids containing a sphingoid base. In fact, several
bacterial species belonging to the human microbiome are capable
of producing sphingolipids with many of these species belonging
to genera within the phylum Bacteroidetes, representing strict
anaerobes that are symbiotic inhabitants of the oral cavity as
well as the gastrointestinal tract (Olsen and Jantzen, 2001). Very
little is known regarding the function of bacterially derived
sphingolipids, yet data indicate that they may function in similar
ways to the sphingolipids of eukaryotic cells. For example, the
sphingolipids produced by B. fragilis have been shown to form
microdomains in the membrane, which have been suggested
to serve as a means of relaying signals of environmental stress
(An et al., 2011). It has also been demonstrated that certain
sphingolipids synthesized by B. fragilis can serve as signals to
subvert the host immune response by modifying the host lipid
environment to negatively regulate (dampen down) the immune
response, thereby mediating a symbiotic association between
the microbiota and the host (An et al., 2014). Hence, a better
understanding of why and when these unique lipids are produced
may enlighten us as to how microbial communities engage in
mutualistic relationships with the host and what changes lead to
pathogenicity.
Although bacterially derived sphingolipids are found in both
healthy and diseased gingival sites, it was notable that the types of
DHCs detected in diseased periodontal tissues was different than
for healthy controls (Nichols and Rojanasomsith, 2006; Nichols
et al., 2011). These results suggest that disease progression is not
associated with simply the presence of sphingolipids, but that
shifts occur in the species of DHCs released by the periodontal
microbiota in the gingival tissue and blood of patients with
periodontitis when compared with healthy controls (Nichols
et al., 2011). Another layer of complexity is added by the results
of in vitro studies using purified fractions of the two major DHCs
produced by P. gingivalis; these studies revealed that PE and PG
DHCs had different effects on eukaryotic cells, due most likely to
the polar head group they possess. For example, PG DHCs alter
fibroblast morphology and increase prostaglandin E2 production
after IL-1β treatment (Nichols et al., 2004) and promote apoptosis
FIGURE 6 | A sphingolipid deficient strain of P. gingivalis is more sensitive to oxidative stress. P. gingivalis W83 and 1PG1780 were grown to early
exponential phase (OD600 = 0.35) in TSBHK media. Cultures were normalized, separated into four aliquots and treated with H2O (as a negative control) or fresh
H2O2 (at 150, 200, or 250 µM). The optical density of cultures were then monitored for 30 h.
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in endothelial cells (Zahlten et al., 2007) as well as chondrocytes
(Röhner et al., 2012). Both whole lipid extracts of P. gingivalis as
well as purified PG DHC interfered with bone mineral deposition
and osteoblast function, while PE DHC showed little effect (Wang
et al., 2010). In parallel, PE DHCs were much more effective at
inducing autoimmunity in a murine model of multiple sclerosis
[called allergic encephalomyelitis (EAE)] (Nichols et al., 2009).
Yet, both DHC classes generally appear to induce inflammatory
responses in disease models and likely engage host cell receptors
(or groups of receptors) via their polar head groups. Further
complicating matters is the fact that DHCs from P. gingivalis are
presented to the host as a mixture with a number of other DHCs
from other bacteria also proficient in synthesis. It is becoming
clear that, like the bacteria that produce them, the sphingolipids
of P. gingivalis are present in both healthy and diseased sites, and
shifts in the community of bacteria depositing them or perhaps
environmental cues that modulate the synthesis of these unique
lipids may contribute to disease progression.
To begin to gain insight into the possible functions of these
sphingolipids in regards to P. gingivalis physiology, we generated
a sphingolipid null mutant; specifically, we deleted a gene
predicted to encode a SPT, PG1780 in strain W83, which is the
enzyme that catalyzes the first committed step in the sphingolipid
biosynthetic pathway. We predicted that the deletion of PG1780
would render P. gingivalis completely deficient for the production
of sphingolipids and indeed our lipid analysis confirmed this
hypothesis (Figure 1). Studies on the intestinal strain B. fragilis,
a close relative of P. gingivalis, using myriocin to inhibit SPT,
determined that sphingolipid synthesis affects survival of this
bacterium during stationary phase, but not the growth of the
bacteria during log phase (An et al., 2011). We demonstrated
that this is also true for P. gingivalis; however, unlike B. fragilis
treated with myriocin, we were surprised to find that the cells
of the P. gingivalis sphingolipid mutant lysed, and cultures of
the mutant visibly decreased in density during stationary phase
(Figure 1 ; Supplementary Figure S1). The discrepancies in our
results may be due to the use of inhibitors in the B. fragilis
experiments rather than a mutant devoid of sphingolipids. In fact,
the authors noted that treatment with myriocin only effectively
blocked the synthesis of two-thirds of the DHCs (An et al., 2011).
Alternatively, this could indicate a distinction in the function of
these lipids in these two different genera. Species of B. fragilis
possess much larger genomes than P. gingivalis (more than
two times greater) and may encode additional systems capable
of compensating for a loss of DHCs. In either case, cell lysis
suggests that there may be conditions during stationary phase,
e.g., nutrient stress or build up of a metabolic by product,
that lead to the up-regulation of sphingolipid biosynthesis in
P. gingivalis (and perhaps also B. fragilis), and these lipids then
play an essential role in stabilizing the cell membrane. Further
studies are underway to determine the environmental cues that
regulate differential expression of PG1780 as well as other genes
involved in the sphingolipids biosynthesis, and additionally,
we are working to determine the levels of the different types
of lipids under various growth conditions and environmental
stresses. Finally, we noted that the growth of 1PG1780 on blood
agar plates was much slower and colonies were much thinner
than colonies of the parental strain (Supplementary Figure S1).
P. gingivalis strain W83 does not form a strong biofilm (Davey
and Duncan, 2006), but in contrast to a planktonic culture,
FIGURE 7 | A schematic model illustrating the potential localization of sphingolipid in the membranes of P. gingivalis based on the results of our
study. The outer membrane of P. gingivalis contains sphingolipids and the cell is cloaked in capsular polysaccharides. (A) Transmission electron micrograph (TEM) of
a P. gingivalis cell (encapsulated strain W83) stained with ruthenium red, showing a dense layer of surface polysaccharides and release of an outer membrane vesicle
(OMV). Graphic representation of the TEM image (B) indicating localization of sphingolipids in the outer membrane (OM) along with select OM proteins co-localized
with dense areas of sphingolipids, representing lipid rafts. The membrane of the OMV is shown to contain sphingolipids as well as the lipid-associated OM proteins.
The OMV is also coated with surface polysaccharides (LPS, APS, and K-antigen capsule).
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growth on the surface of a blood plate may more accurately
model the environment of subgingival plaque. Our results suggest
that growth of 1PG1780 is compromised on solid surfaces,
and additional studies using more heavily fimbriated strains
of P. gingivalis (W50, 33277, or 381) could provide a greater
understanding regarding the importance of sphingolipids in
the colonization and/or invasion of this organism. Importantly,
the orthologs of PG1780 in these other strains show 99%
identity.
Our initial interest in sphingolipid synthesis began during
an investigation of a trans-acting anti-sense RNA (asRNA)
positioned within a 77-bp inverted repeat element and located
just upstream of an operon involved in production of the K1
capsular polysaccharide in P. gingivalis strain W83 (Bainbridge
et al., 2015). A bioinformatic search revealed that multiple
sites bearing a high degree of sequence identity to the asRNA
are located throughout the genome of P. gingivalis, and one
of these regions was found near PG1786 (data not shown),
a gene located just downstream of PG1780. Some of the
findings from our current study suggest that sphingolipids may
play a role in the deployment and/or anchoring of surface
polysaccharides to the outer membrane. The precise identity of
the lipid moiety responsible for covalently anchoring capsular
polysaccharides to the outer membrane of bacteria has only
been definitively identified in a few species. For example, Willis
et al. (2013), in a recent report, have observed the direct
covalent attachment of capsular polysaccharide to a glycerol
phospholipid species containing a lyso-phosphatidylglycerol
motif. The proximity of PG1780 to a potential target of a
trans-acting anti-sense RNA as well as the altered surface
polysaccharides of in 1PG1780 make it tempting to speculate
that sphingolipids could potentially play a role in anchoring
surface polysaccharides to the outer leaflet in P. gingivalis.
Another striking discovery from our study was that 1PG1780
mutant displayed an overall decrease in the amount of surface
polysaccharides, with a shift to low levels of K-antigen and
higher levels of APS. Our current working hypothesis is that
the synthesis of higher levels of APS may be either an indirect
effect, i.e., a compensatory mechanism in response to the lack of
sphingolipids; or K-antigen capsule and APS may be inversely
regulated. We are currently taking a biochemical approach to
determine the carbohydrate composition of the sphingolipid
mutant compared to the parent strain to further clarify our
results.
Porphyromonas gingivalis is known to be highly proteolytic,
with major activity from a class of endopeptidases known as
gingipains. These proteases are essential to nutrient acquisition
and are located on the cell surface and released into the
surroundings (Curtis et al., 1999a). APS is immunologically
connected to the post-transcriptional modification of Arg-
gingipains (RgpA), since a monoclonal antibody (MAb 1B5)
raised against RgpA, cross reacts with APS (Curtis et al., 1999b;
Paramonov et al., 2005). The current model is that Arg-gingipains
are covalently anchored to APS, suggesting that their synthesis
would be coordinated; yet our data indicate that the synthesis
of APS and gingipain activity are not necessarily linked, since
APS was detected at higher levels in the PG1780 mutant,
yet gingipain activity was down. To our knowledge this the
first report of a P. gingivalis mutant strain that over-produces
APS.
It is also important to note that we were able to recover DHCs
from our outer membrane vesicle preparations of P. gingivalis
strain W83, which would seem to indicate that DHCs are
present in the outer leaflet of this organism. As discussed
above, sphingolipids are able to partition into membrane
subcompartments with other lipids, often sterols, and integral
membrane proteins referred to as lipid rafts. Investigations in
B. fragilis revealed that inhibition of sphingolipid production
resulted in a complete loss of lipid rafts, and it is probable
that deletion of PG1780 could result in the destabilization
of lipid rafts in P. gingivalis. Though speculative, we suggest
that lipid rafts in the outer leaflet could facilitate the
efficient transport or localization of some species of surface
polysaccharides (or potentially gingipains) to the cell surface,
and without sphingolipids, the protein components of lipid
rafts may be destabilized, leading to inefficient transport.
Overall, our results suggest that DHCs are present at the
outermost surface of the bacterial cell, and based on our
results and previous work with sphingolipids, we suggest a
model whereby sphingolipids may serve to regulate surface
polysaccharides or attach/deliver them to the outer surface of the
cell (Figure 7).
CONCLUSION
We have uncovered the first enzyme in the pathway for
generating sphingolipids in the oral pathobiont P. gingivalis.
It has been well established that DHCs derived from this
bacterium contribute to its virulence, and the results of
our study demonstrate that these unique lipids are also
critical to the long-term persistence and presentation of
other virulence attributes, such as gingipains and capsular
polysaccharide. As mixed populations of bacterially derived
sphingolipids can be detected at both sites of health and
disease, it is important to determine what factors drive the
synthesis pathways toward the production of the different
types of sphingolipid species, especially those enriched at
diseased sites. Further investigations into the regulation of
sphingolipid biosynthesis in the Bacteroidetes and the specific
enzymes involved in their production will likely increase our
understanding of the balance between commensalism and
disease.
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